Form 990 for tax year 2023
Filed by LOBULAR BREAST CANCER ALLIANCE INC.
Totals
- Total revenue
- $1,043,541
- Total expenses
- $743,557
- Contributions and grants received
- $1,027,757
- Grants paid
- $317,203
- Program service revenue
- $0
- Investment income
- $15,325
- Other revenue
- $459
- Total assets, end of year
- $640,464
- Total liabilities, end of year
- $42,203
- Net assets or fund balances, end of year
- $598,261
- Program services expenses (Part IX)
- $569,234
- Management and general expenses
- $77,193
- Fundraising expenses
- $97,130
- Program service expenses (Part III)
- $569,234
Program services were 76.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$1,027,757
-
3 · Investment income
total $15,325 · excluded $15,325
-
11a · Other revenue: MISC. REVENUE
total $459 · related or exempt $459
-
11e · Other revenue, total
$459
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $183,500 · program services $183,500
-
2 · Grants to domestic individuals
total $26,033 · program services $26,033
-
3 · Grants to foreign organizations and individuals
total $107,670 · program services $107,670
-
5 · Compensation of officers, directors and key employees
total $164,010 · program services $110,870 · management and general $23,834 · fundraising $29,306
-
7 · Other salaries and wages
total $97,190 · program services $46,740 · management and general $1,598 · fundraising $48,852
-
9 · Other employee benefits
total $555 · management and general $555
-
10 · Payroll taxes
total $22,597 · program services $14,332 · management and general $2,138 · fundraising $6,127
-
11b · Fees: legal
total $350 · management and general $350
-
11c · Fees: accounting
total $33,288 · management and general $33,288
-
11g · Fees: other
total $67,845 · program services $58,525 · management and general $3,860 · fundraising $5,460
-
12 · Advertising and promotion
total $2,964 · program services $673 · management and general $125 · fundraising $2,166
-
13 · Office expenses
total $299 · program services $40 · management and general $23 · fundraising $236
-
14 · Information technology
total $10,186 · program services $5,744 · management and general $349 · fundraising $4,093
-
17 · Travel
total $11,502 · program services $11,502
-
19 · Conferences, conventions and meetings
total $1,604 · program services $375 · management and general $1,229
-
23 · Insurance
total $3,008 · management and general $3,008
-
24a · Other expenses: BANK & MERCHANT FEES
total $5,463 · management and general $5,168 · fundraising $295
-
24b · Other expenses: PRINTING, POSTAGE & SHI
total $3,350 · program services $2,565 · management and general $190 · fundraising $595
-
24c · Other expenses: REGULATORY FILING FEES
total $1,478 · management and general $1,478
-
24d · Other expenses: DUES & SUBSCRIPTIONS
total $665 · program services $665
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $16,812 · end of year $63,719
-
2 · Savings and temporary cash investments
beginning of year $312,806 · end of year $569,292
-
3 · Pledges and grants receivable
beginning of year $49,139 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $1,631 · end of year $7,453
-
17 · Accounts payable and accrued expenses
beginning of year $82,111 · end of year $42,203
-
27 · Net assets without donor restrictions
beginning of year $298,277 · end of year $497,677
-
28 · Net assets with donor restrictions
end of year $100,584
Mission and programs · 2023
Mission
AS THE ONLY ORGANIZATION IN THE US DEDICATED TO INVASIVE LOBULAR BREAST CANCER (ILC), LBCA'S MISSION IS TO MAKE ALL WHO ARE TOUCHED BY ILC AWARE OF ITS UNIQUE CHARACTERISTICS AND THE CRITICAL NEED FOR MORE ILC RESEARCH; TO BE THE GO-TO SOURCE FOR (CONT'D IN SCHEDULE O) INFORMATION ON ILC STUDIES, CLINICAL TRIALS AND EDUCATIONAL TOOLS; TO FOSTER PARTNERSHIPS AMONG PATIENTS, SCIENTISTS, CLINICIANS, AND BREAST CANCER ORGANIZATIONS TO INCREASE DIALOGUE ABOUT ILC AND RESEARCH ADVOCACY; AND TO FUND VITAL ILC RESEARCH.
Activities or mission (Part I)
EDUCATING THE MEDICAL & GENERAL PUBLIC ABOUT INVASIVE LOBULAR CARCINOMA (ILC)/LOBULAR BREAST CANCER, PROVIDING TRAINING & INFORMATION TO SUPPORT VOLUNTEERS SEEKING TO ADVOCATE FOR GREATER ILC AWARENESS AND MORE RESEARCH, PROMOTING PATIENT & RESEARCHER COLLABORATIONS, AND MAKING GRANTS FOR ILC RESEARCH.
-
DURING THE FISCAL YEAR, LBCA:-INITIATED AND COLLABORATED WITH GLOBAL NETWORK OF ILC ADVOCATES AND RESEARCHERS TO WRITE A DECLARATION CLAIMING OCTOBER 15TH AS GLOBAL LOBULAR BREAST CANCER AWARENESS DAY AND INITIATED PLANNING WORK WITH A PR COMPANY TO BROADEN MESSAGE TO ALL WOMEN OVER AGE 40-LAUNCHED LOCAL ADVOCACY TEAM (LAT) INITIATIVE TO ENCOURAGE AND SUPPORT LOCAL ADVOCATES CONDUCTING EDUCATION AND RESEARCH ADVOCACY IN THEIR COMMUNITIES-PRODUCED BROCHURE ABOUT ILC AND LBCA AND TRANSLATED INTO OVER 19 DIFFERENT LANGUAGES-PRODUCED PATIENT FAQ ON TISSUE DONATION-FUNDED ILC RESEARCH GRANTS WITH (CONT'D IN SCHEDULE O) THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ASCO / CONQUER CANCER FOUNDATION, AND AMERICAN ASSOCIATION FOR CANCER RESEARCH-CREATED A MOVIE TO ENCOURAGE PARTICIPATION IN BREAST CANCER CLINICAL TRIALS AND SHARED ON OUR WEBSITE AND SOCIAL MEDIA OUTLETS-SPONSORED AND PARTICIPATED IN THE 2023 INTERNATIONAL ILC SYMPOSIUM HELD IN PITTSBURGH, PA-SPONSORED FIRST EVER EDUCATIONAL SESSION ON ILC AT THE SAN ANTONIO BREAST CANCER SYMPOSIUM 2023-PRODUCED TWO POSTERS PRESENTED AT BREAST CANCER CONFERENCES ON PATIENT EXPERIENCE WITH SURGICAL TREATMENT PLANNING-DEVELOPED AND SHARED ON WEBSITE AND SOCIAL MEDIA LAY SUMMARIES OF ALL ILC POSTERS PRESENTED AT SABCS 23, TO MAKE THE RESEARCH PRESENTED ACCESSIBLE TO LAY AUDIENCES-TRANSLATED QUESTIONS FOR YOUR DOCTOR AND OTHER PATIENT FACING EDUCATIONAL MATERIALS INTO OVER 16 LANGUAGES AND SHARED THESE ON ORGANIZATIONAL WEBSITE-MANAGED WEBSITE WITH OVER 44,000 VISITS THAT PROVIDES DETAILED INFORMATION FOR THE PUBLIC ABOUT INVASIVE LOBULAR BREAST CANCER (ILC), ILC RESEARCH, CLINICAL TRIALS AND PATIENT ADVOCACY OPPORTUNITIES-HOSTED 3 WEBINARS FOR ILC PATIENT ADVOCATES ON RESEARCH AND OTHER TOPICS, AND PROVIDED 21 TRAVEL SCHOLARSHIPS TO PATIENT ADVOCATES TO ATTEND TRAININGS AND CONFERENCES-SPONSORED SCIENTIFIC ADVISORY BOARD MEETINGS TO INVOLVE ILC RESEARCHERS IN ADVOCACY AND IN THE DEVELOPMENT OF THE INFORMATION LBCA DISSEMINATES-SPONSORED PATIENT ADVOCATE ADVISORY BOARD MEETINGS TO INVOLVE ILC PATIENT ADVOCATES IN ILC AWARENESS RAISING ACTIVITIES AND STRATEGIC PLANNING-PUBLISHED MONTHLY NEWSLETTER REACHING OVER 5,800 SUBSCRIBERS
Expenses $569,234 · Grants $317,202
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Laurie B Hutcheson MsLAURIE B HUTCHESON MS
PRESIDENT, ED, & DIRECTOR
- Total calculated
- $112,644
- From this org
- $112,644
- From related orgs
- $0
- Other
- $0
- Hours/week
- 50
-
Tanya Martin-DickTANYA MARTIN-DICK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ramlah Nehring PhDRAMLAH NEHRING PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Judy McDevittJUDY MCDEVITT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Kathryn KrantzKATHRYN KRANTZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Tracy Cushing MD MPHTRACY CUSHING MD MPH
DIRECTOR & BOARD CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Robert W Oakes Jr CPA MBAROBERT W OAKES JR CPA MBA
TREASURER & DIRECTOR
- Total calculated
- $0
- Hours/week
- 3
-
Mason Mitchell-Daniels MSW MPHMASON MITCHELL-DANIELS MSW MPH
VICE PRESIDENT & COO
- Total calculated
- $45,483
- From this org
- $45,483
- From related orgs
- $0
- Other
- $0
- Hours/week
- 20
-
Joseph C Hutcheson II JD MBAJOSEPH C HUTCHESON II JD MBA
SECRETARY & GEN COUNSEL
- Total calculated
- $0
- Hours/week
- 10
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
TO FUND TWO ILC INNOVATION RESEARCH GRANTS
-
TO FUND YOUNG INVESTIGATOR RESEARCH GRANT
-
$11,000
TO SPONSOR THE ILC POSTER SESSION AT 2023 INTERNATIONAL ILC SYMPOSIUM AND TO SUPPORT TRAVEL FOR 4 SPEAKERS TO EVENT
-
TO FUND FIRST PORTION OF IMAGING RESEARCH FELLOWSHIP
-
TO SPONSOR ILC EDUCATIONAL SESSION AT SABCS 2023
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $107,670
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | GRANTS TO RECIPIENTS LOCATED IN THE REGION | — | $107,670 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | $95,000 | WIRE PAYMENT | $0 | — | — |
| EUROPE (INCLUDING ICELAND & GREENLAND) | $10,000 | WIRE PAYMENT | $0 | — | — |
| EUROPE (INCLUDING ICELAND & GREENLAND) | $2,670 | CREDIT CARD PAYMENT | $0 | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 3
- Other grantees (Part II line 3)
- —
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 30 January 2025
- IRS schema version
- 2023v6.0
- Source object
- 202540309349301309
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.